Acupuncture and Moxibustion Ward II（南岗总院）

Acupuncture Department, Ward 2

2022.11

The Second Inpatient Ward of the Acupuncture Department at the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine is one of Heilongjiang Province’s key specialties for brain diseases. It is a comprehensive department integrating medical care, teaching, and scientific research, as well as an advanced collective and model department of the hospital. In 2011, Acupuncture Ward 2 was approved as a key development unit for the provincial-level key specialized disease of Heilongjiang Province—brain diseases in traditional Chinese medicine. The department has distinctive advantages in treating stroke through a combined acupuncture-and-medication approach and has promoted its acupuncture methods for stroke treatment nationwide. As a traditional acupuncture department, it has prominent advantages in stroke treatment, including the use of distinctive formulas for hemorrhagic cerebrovascular diseases; intravenous drip infusion of traditional Chinese medicine extracts for ischemic cerebrovascular diseases; and distinctive acupuncture methods combined with a series of traditional Chinese medicine decoctions for stroke to treat stroke-related hemiplegia, aphasia, and bulbar paralysis, each with its own features and advantages. The efficacy of the five-in-one method for treating facial nerve paralysis has been demonstrated in clinical practice. The department has developed a series of traditional Chinese medicine preparations, such as Zhongfengting for treating various cerebrovascular diseases; when combined with acupuncture, tuina, and rehabilitation exercise therapy, it produces better therapeutic results.

The Second Inpatient Ward of the Acupuncture Department currently has 60 beds, 2 general outpatient consultation rooms, and an average of more than 30 outpatient visits per day. It has a first-rate, high-quality nursing service team in the province. The department’s main areas of strength include senile dementia, stroke, vertigo, Wei syndrome, and facial paralysis. It actively develops specialized fields and specialty diseases and expands acupuncture rehabilitation medicine on a large scale. It specializes in treating neurological disorders such as cerebral infarction, cerebral hemorrhage, cerebral atrophy, dementia, hypertension, facial paralysis, epilepsy, headache, vertigo, insomnia, autonomic nervous system dysfunction, hyperactivity disorder, cervical spondylosis, lumbar spine disease, spinal cord lesions, muscle diseases, multiple sclerosis, and others, using acupuncture, traditional Chinese medicine, and integrated Chinese-Western medicine.

The talent structure of the Second Inpatient Ward of the Acupuncture Department is well balanced, with strong innovation capabilities and considerable development potential. It currently has 23 medical and nursing staff members, including 1 nationally renowned traditional Chinese medicine physician, 1 chief physician, 3 associate chief physicians, 4 attending physicians, 2 postdoctoral fellows, 6 doctors of medicine, 1 master of medicine, 1 doctoral supervisor, and 1 master’s supervisor. The department undertakes medical care, scientific research, teaching, and other duties. Department leaders and leaders responsible for the development of key specialty diseases hold positions such as vice chairs and council members in important domestic academic organizations; they have participated in and chaired domestic and international academic conferences more than 10 times in total. As the teaching and research section for acupuncture therapy, the Second Inpatient Ward also undertakes clinical teaching. In addition to routine daily teaching for undergraduate, master’s, and doctoral students, it receives every year international students and trainees from the United States, Russia, the United Kingdom, South Korea, Japan, various African countries, Hungary, and other countries, making an active contribution to bringing acupuncture techniques to the entire world. The Second Inpatient Ward undertakes approximately 100 or more national-, provincial-, ministerial-, and bureau-level research projects, has received more than 20 awards, including Science and Technology Progress Awards and Scientific and Technological Achievement Awards, has published more than 500 academic papers, has participated in compiling more than 30 textbooks and scholarly works, has trained more than 100 domestic and international doctoral and master’s students, and has undertaken research work for multiple national clinical pharmacology bases. It has received hundreds of domestic and international professional trainees for study in the department.